Download Docs
Export

ABRAXIS PHARMACEUTICAL PRODUCTS

78857203 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed April 8, 2006
Serial No. 78857203
Registered Oct. 9, 2007
Registration No. 3,309,636
Interlocutory Attorney ELIZABETH WINTER
Class Pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace element preparations in the nature of mineral supplements for human consumption, vitamins, micronutrients, namely, nutritional supplements, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery systems composed of nanoparticles sold as an integral component of drugs; injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases in the form of prefilled IV bags as a unit, sold separately or with devices for intravenous administration, namely, transfer pins, vials, needles, adaptors and tamper resistant seals sold as a kit; 006; 018; 044; 046; 051; 052; 100; 101; 102
ABRAXIS PHARMACEUTICAL PRODUCTS
Status Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Opposition 91199307
Celgene Corporation v. Ablexis, LLC
  • Ablexis, LLC;
  • Celgene Corporation;
Last Updated: 2 months, 2 weeks ago
Filing Date # Docket Text